The Efficacy and Safety of Rapamycin in Children with Tuberous Sclerosis: A Cross-sectional Study

OBJECTIVES: Mutations in TSC1 or TSC2 genes have been proposed as the main causative factors responsible for developing Tuberous Sclerosis Complex (TSC). Given the effect of these two genes on the mTOR pathway, rapamycin has emerged as a novel therapeutic agent. The present study evaluated the effec...

Descripción completa

Detalles Bibliográficos
Autores principales: TEHRANI, Fateme, KHOSROSHAHI, Nahideh, KEIHANI DOUST, Zarrin, DABIRAN, Soheila, ZARKESH, Mohammad Reza
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Shahid Beheshti University of Medical Sciences 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10114273/
https://www.ncbi.nlm.nih.gov/pubmed/37091468
http://dx.doi.org/10.22037/ijcn.v17i2.36243

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10114273/
https://www.ncbi.nlm.nih.gov/pubmed/37091468
http://dx.doi.org/10.22037/ijcn.v17i2.36243

Ejemplares similares